vancomycin has been researched along with mupirocin in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (9.43) | 18.2507 |
2000's | 13 (24.53) | 29.6817 |
2010's | 29 (54.72) | 24.3611 |
2020's | 6 (11.32) | 2.80 |
Authors | Studies |
---|---|
Broom, NJ; Cassels, R; Cheng, HY; Elder, JS; Hannan, PC; Masson, N; O'Hanlon, PJ; Pope, A; Wilson, JM | 1 |
Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
Castanheira, M; Deshpande, LM; DiPersio, J; Jones, RN; Mendes, RE; Saubolle, MA | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
Hurdle, JG; Lee, RE; Sun, D; Yendapally, R | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
Hu, W; Lv, F; Shi, W; Xing, D; Yang, L; Yang, S; Yang, Y; Zhao, Z | 1 |
Estévez-Braun, A; Feresin, GE; Machín, F; Martín, P; Peña, R; Tapia, A | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Abdelghany, TM; Elkabbany, AH; Ghiaty, A; Hagras, M; Hegazy, YA; Mayhoub, AS; Mohammad, H; Seleem, MN | 1 |
Dayal, N; Onyedibe, KI; Sintim, HO | 1 |
Bailey, AM; Dao, TT; de Mattos-Shipley, KMJ; Simpson, TJ; Song, Z; Spencer, J; Takebayashi, Y; Williams, K; Willis, CL | 1 |
Dayal, N; Gribble, WM; Onyedibe, KI; Sintim, HO | 1 |
Matsumoto, K; Takahashi, A | 1 |
Casewell, MW | 1 |
Almirante Gragera, B; San José Laporte, A; Selva O'Callaghan, A; Vilardell Tarrés, M | 1 |
Beuth, J; Pulverer, G; Schierholz, JM | 1 |
Cirioni, O; Ghiselli, R; Giacometti, A; Goffi, L; Mocchegiani, F; Orlando, F; Riva, A; Saba, V; Scalise, G; Viticchi, C | 1 |
Patel, R | 1 |
Abb, J | 1 |
Buiting, AG; Maraha, B; van Halteren, J; Verzijl, JM; Wintermans, RG | 1 |
Cieślikowski, T; Nowak, T; Rózalska, M; Szewczyk, EM | 1 |
Buehlmann, M; Dangel, M; Fenner, L; Fluckiger, U; Frei, R; Widmer, AF | 1 |
Kluytmans, JA; van Rijen, MM | 1 |
Davidson, SM; Dejoie, P; Gulczynski, D; Hunter, DJ; Kim, DH; Li, L; Martha, JF; Miley, GB; Parazin, SJ; Richmond, JC; Shaw, JD; Spencer, M | 1 |
Greene, L; Kirshner, R; Walsh, EE | 1 |
Farrell, DJ; Love, WG; Rhys-Williams, W; Robbins, M | 1 |
Liu, C | 1 |
Kavanagh, K; Parham, K; Rutherford, KD | 1 |
Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
Cabrita, A; Carvalho, MJ; Mendonça, D; Rocha, A; Rodrigues, A; Teixeira, L | 1 |
Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
Bosco, JA; Hadley, S; Hutzler, L; Mehta, S; Phillips, M; Slover, J | 1 |
Frimodt-Møller, N; Vingsbo Lundberg, C | 1 |
Crispell, EK; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; McDanel, JS; Riahi, F; Richter, SS; Satola, SW | 1 |
Braun, B; Cavanaugh, JE; Chiang, HY; Diekema, DJ; Hafner, J; Herwaldt, LA; Hickok, J; Moody, J; Perencevich, EN; Perlin, JB; Richards, CL; Schweizer, ML; Septimus, E; Ward, MA | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Abella, L; Rogers, T; Sporer, SM | 1 |
Fang, H; Fröding, I; Gian, B; Hæggman, S; Nord, CE; Tollström, UB; Ullberg, M | 1 |
Hiramatsu, K; Hishinuma, T; Matsuo, M; Morimoto, Y; Sasaki, T; Singh, M | 1 |
Caputo, GA; Hong, S; Kuroda, K; Mortazavian, H; Nadres, ET; Takahashi, H; Younger, JG | 1 |
Campbell, D; Craig, JC; Johnson, DW; Mudge, DW; Strippoli, GF; Tong, A | 1 |
Bae, IG; Cho, OH; Hong, JM; Hong, SI; Kim, S; Kim, T; Park, KH; Song, JY | 1 |
Bogdan, C; Kiefer, A; Melichar, VO | 1 |
Basaraba, RJ; Jabra-Rizk, MA; Khoueir, N; Leid, JG; Shikani, AH; Shikani, HJ | 1 |
Hardesty, CK; Mistovich, RJ; Poe-Kochert, C; Shimberg, JL; Son-Hing, JP; Thompson, GH | 1 |
Allen, B; Chaudhry, A; Hayes, S; Paylor, M | 1 |
Gargvanshi, S; Gutheil, WG | 1 |
2 review(s) available for vancomycin and mupirocin
Article | Year |
---|---|
New approaches to prevention of staphylococcal infection in surgery.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Carrier State; Chemoprevention; Chlorhexidine; Cross Infection; Humans; Mupirocin; Patient Isolation; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2008 |
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Topics: Administration, Intranasal; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Antifungal Agents; Catheter-Related Infections; Device Removal; Humans; Injections, Intravenous; Mupirocin; Mycoses; Peritoneal Dialysis; Peritonitis; Randomized Controlled Trials as Topic; Vancomycin | 2017 |
3 trial(s) available for vancomycin and mupirocin
Article | Year |
---|---|
Auditory function after application of ototopical vancomycin and mupirocin solutions in a murine model.
Topics: Animals; Anti-Bacterial Agents; Evoked Potentials, Auditory, Brain Stem; Female; Granulation Tissue; Injections, Intralesional; Mice; Mice, Inbred CBA; Mupirocin; Otitis Media; Vancomycin | 2011 |
Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cardiac Surgical Procedures; Cefazolin; Cefuroxime; Chlorhexidine; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Nose; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin; Young Adult | 2015 |
Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Screening and Decolonization to Reduce Surgical Site Infection in Elective Total Joint Arthroplasty.
Topics: Administration, Intranasal; Aged; Anti-Infective Agents, Local; Arthroplasty; Arthroplasty, Replacement; Chlorhexidine; Elective Surgical Procedures; Female; Humans; Incidence; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Nasal Cavity; Preoperative Care; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2016 |
48 other study(ies) available for vancomycin and mupirocin
Article | Year |
---|---|
The chemistry of pseudomonic acid. 17. Dual-action C-1 oxazole derivatives of pseudomonic acid having an extended spectrum of antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Mupirocin; Structure-Activity Relationship | 1996 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Humans; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Fibroblasts; Humans; Male; Mice; Pyrrolidinones; Staphylococcal Skin Infections; Tenuazonic Acid | 2009 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Oligopeptides; Structure-Activity Relationship | 2014 |
Domino Synthesis of Embelin Derivatives with Antibacterial Activity.
Topics: Aldehydes; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Catalysis; Gram-Positive Bacteria; Molecular Structure; Proline; Staphylococcus aureus; Stereoisomerism | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cell Line; Chemical Phenomena; Cricetinae; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxadiazoles; Rats; Solubility; Structure-Activity Relationship; Thiazoles | 2018 |
SF
Topics: | 2021 |
Cladobotric Acids: Metabolites from Cultures of
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2022 |
Membrane acting Povarov-Doebner derived compounds potently disperse preformed multidrug resistant Gram-positive bacterial biofilms.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Biofilms; Drug Resistance, Multiple, Bacterial; Humans; Mammals; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests | 2022 |
[Present status of MRSA infections].
Topics: Carrier State; Coagulase; Cross Infection; Humans; Methicillin Resistance; Mupirocin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
New threats to the control of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Reservoirs; Drug Resistance, Microbial; Hospital Costs; Humans; Infection Control; Methicillin Resistance; Mupirocin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
[Methicillin-resistant Staphylococcus aureus infection in a geriatric unit for acutely ill].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Female; Humans; Male; Methicillin; Methicillin Resistance; Mupirocin; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1998 |
Adherent bacteria and activity of antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Drug Resistance, Microbial; Enzyme Inhibitors; Lactams; Mupirocin; Rifampin; Structure-Activity Relationship; Vancomycin | 1999 |
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Blood Vessels; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Vancomycin Resistance | 2000 |
Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carrier State; Contraindications; Humans; Liver Transplantation; Methicillin Resistance; Mupirocin; Nose; Risk; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2001 |
In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mupirocin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin.
Topics: Administration, Oral; Administration, Topical; beta-Lactam Resistance; Drug Evaluation; Humans; Methicillin Resistance; Mupirocin; Ointments; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2002 |
Plasmids of Staphylococcus cohnii isolated from the intensive-care unit.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriocins; Chloramphenicol; Ciprofloxacin; Clindamycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Hospitals, Pediatric; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Plasmids; Poland; Staphylococcus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers.
Topics: Aged; Aged, 80 and over; Anal Canal; Anti-Bacterial Agents; Anti-Infective Agents, Local; Carrier State; Chlorhexidine; Female; Humans; Male; Methicillin Resistance; Middle Aged; Mupirocin; Nose; Pharynx; Povidone-Iodine; Rectum; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery.
Topics: Administration, Intranasal; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carrier State; Cefazolin; Chlorhexidine; Female; Humans; Male; Mass Screening; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Nasal Cavity; Ointments; Orthopedics; Polymerase Chain Reaction; Prospective Studies; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2010 |
Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery.
Topics: Administration, Intranasal; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Confounding Factors, Epidemiologic; Female; Humans; Incidence; Infection Control; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; New York; Ointments; Research Design; Risk Assessment; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2011 |
Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Daptomycin; Diterpenes; Fusidic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mupirocin; Polymerase Chain Reaction; Porphyrins; Sequence Analysis, DNA; Vancomycin | 2011 |
The bundled approach to MRSA surgical site infection prevention: is the whole greater than the sum of its parts?: comment on "Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery".
Topics: Administration, Intranasal; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Humans; Infection Control; Medical Staff; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nursing Staff; Ointments; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Ceftazidime; Cohort Studies; Female; Fluconazole; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mupirocin; Peritoneal Dialysis; Peritonitis; Treatment Outcome; Vancomycin | 2012 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
Impact of preoperative MRSA screening and decolonization on hospital-acquired MRSA burden.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Chi-Square Distribution; Chlorhexidine; Community-Acquired Infections; Cross Infection; Elective Surgical Procedures; Hospitals, University; Humans; Incidence; Infection Control; Mass Screening; Medication Adherence; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nasal Mucosa; Orthopedic Procedures; Patient Admission; Prevalence; Program Evaluation; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2013 |
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Female; Fusidic Acid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin; Wound Infection | 2013 |
Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; United States; Vancomycin; Vancomycin Resistance | 2014 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Methicillin-resistant Staphylococcus aureus in Stockholm, Sweden: Molecular epidemiology and antimicrobial susceptibilities to ceftaroline, linezolid, mupirocin and vancomycin in 2014.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Genotype; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Staphylococcal Infections; Sweden; Vancomycin | 2016 |
In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin.
Topics: Anti-Bacterial Agents; Isoleucine-tRNA Ligase; Microbial Sensitivity Tests; Mupirocin; Mutation; Polymorphism, Single Nucleotide; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2017 |
A Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cells, Cultured; Erythrocytes; Fibroblasts; Hemolysis; Humans; Hydrogen-Ion Concentration; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Polymers; Staphylococcus aureus; Vancomycin | 2017 |
Prevalence and Microbiological Characteristics of qacA/B-Positive Methicillin-Resistant Staphylococcus aureus Isolates in a Surgical Intensive Care Unit.
Topics: Aged; Anti-Infective Agents, Local; Bacterial Proteins; Chlorhexidine; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Humans; Intensive Care Units; Male; Membrane Transport Proteins; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Prevalence; Republic of Korea; Retrospective Studies; Staphylococcal Infections; Trans-Activators; Vancomycin | 2018 |
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Topical therapy for refractory rhinosinusitis caused by methicillin-resistant Staphylococcus aureus: First report in a prospective series.
Topics: Administration, Intranasal; Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cellulose; Culture Techniques; Debridement; Endoscopy; Female; Humans; Instillation, Drug; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mometasone Furoate; Mupirocin; Nebulizers and Vaporizers; Prospective Studies; Rhinitis; Saline Solution; Sinusitis; Staphylococcal Infections; Therapeutic Irrigation; Tobramycin; Treatment Outcome; Vancomycin | 2018 |
Surgical site infection prevention protocol for pediatric spinal deformity surgery: does it make a difference?
Topics: Administration, Intranasal; Adolescent; Antibiotic Prophylaxis; Baths; Child; Chlorhexidine; Female; Humans; Incidence; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Patient Care Bundles; Powders; Scoliosis; Spinal Fusion; Surgical Wound Infection; Vancomycin | 2020 |
Evaluation of the reliability of MRSA screens in patients undergoing universal decolonization.
Topics: Administration, Intranasal; Aged; Anti-Bacterial Agents; Cohort Studies; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Nose; Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Rifabutin; Rifamycins; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |